NEW YORK (GenomeWeb News) — Genetic Technologies today said it has licensed its non-coding DNA patents to Viennese diagnostics company GenoSense.
Under the nine-year deal, GenoSense bought worldwide licensing rights to use Genetic Technologies’ technology in its anti-aging diagnostics and preventive testing services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.